FOLH1 and prostate cancer: Moreover, PET imaging showed excellent sensitivity and specificity for recurrent prostate cancer and promising results in the detection of bone metastasis, especially when the Prostate-specific membrane antigen (PSMA) is targeted by radioligands such as 68Ga (Gallium 68) [7,8].